» Articles » PMID: 17004096

Cerebral Malaria in Spite of Peripheral Parasite Clearance in a Patient Treated with Atovaquone/proguanil

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2006 Sep 28
PMID 17004096
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral malaria, the most frequent complication of falciparum malaria, is usually predicted by an increased count of asexual parasites in peripheral blood. We report a case of a female returnee from Ghana who developed cerebral malaria in spite of parasite clearance in peripheral blood after therapy with atovaquone/proguanil.

Citing Articles

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.

Staines H, Burrow R, Teo B, Chis Ster I, Kremsner P, Krishna S J Antimicrob Chemother. 2017; 73(3):581-595.

PMID: 29237012 PMC: 5890752. DOI: 10.1093/jac/dkx431.

References
1.
Hogh B, Clarke P, Camus D, Nothdurft H, Overbosch D, Gunther M . Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Lancet. 2000; 356(9245):1888-94. DOI: 10.1016/s0140-6736(00)03260-8. View

2.
Looareesuwan S, Chulay J, Canfield C, Hutchinson D . Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg. 1999; 60(4):533-41. DOI: 10.4269/ajtmh.1999.60.533. View

3.
Wichmann O, Muehlen M, Gruss H, Mockenhaupt F, Suttorp N, Jelinek T . Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. Malar J. 2004; 3:14. PMC: 425592. DOI: 10.1186/1475-2875-3-14. View

4.
Llanos-Cuentas A, Campos P, Clendenes M, Canfield C, Hutchinson D . Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru. Braz J Infect Dis. 2001; 5(2):67-72. DOI: 10.1590/s1413-86702001000200004. View

5.
Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M . Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis. 2004; 190(9):1541-6. DOI: 10.1086/424469. View